Abstract: Methods and devices for use in reducing the appearance of dimpled skin or other undesirable appearance of skin in a cellulitic region of a patient are provided. The methods include the steps of disrupting fibrous septae located beneath the skin of a cellulitic region and introducing a composition beneath the skin, the composition being effective to reduce or prevent regrowth of the fibrous septae.

Abstract: Methods and devices for use in reducing the appearance of dimpled skin or other undesirable appearance of skin in a cellulitic region of a patient are provided. The methods include the steps of disrupting fibrous septae located beneath the skin of a cellulitic region and introducing a composition beneath the skin, the composition being effective to reduce or prevent regrowth of the fibrous septae.

Abstract: Methods and devices for use in reducing the appearance of dimpled skin or other undesirable appearance of skin in a cellulitic region of a patient are provided. The methods include the steps of disrupting fibrous septae located beneath the skin of a cellulitic region and introducing a composition beneath the skin, the composition being effective to reduce or prevent regrowth of the fibrous septae.

Abstract: The invention relates to novel polypeptide analogues of GLP-1 and exendin-4. The polypeptide, in a preferred embodiment, is insulinotropic and long-acting. Preferably, the polypeptide's insulinotropic effect is comparable to or exceeds the effect of an equimolar amount of GLP-1 or exendin-4. The invention also relates to a method of treating a subject with diabetes, comprising administering to the subject the polypeptide of the invention in an amount that has an insulinotropic effect. The invention also relates to methods of using GLP-1, exendin-4, and polypeptide analogues thereof for neuroprotective and neurotrophic effects.

Abstract: The invention relates to novel polypeptide analogues of GLP-1 and exendin-4. The polypeptide, in a preferred embodiment, is insulinotropic and long-acting. Preferably, the polypeptide's insulinotropic effect is comparable to or exceeds the effect of an equimolar amount of GLP-1 or exendin-4. The invention also relates to a method of treating a subject with diabetes, comprising administering to the subject the polypeptide of the invention in an amount that has an insulinotropic effect. The invention also relates to methods of using GLP-1, exendin-4, and polypeptide analogues thereof for neuroprotective and neurotrophic effects.

Abstract: A method and system is provided that in a fully automated manner crawls web sites and identifies specific types of web pages, then extracts targeted data from those web pages. One or more text nodes containing product-related information on a first web page are first identified, and the locations of those test nodes are described using one or more vectors. The vectors are then analyzed to identify one or more patterns and to generate a model from those patterns that discriminates between text nodes that contain product-related information and text nodes that do not contain product-related information on a second web page. The model can then be used to crawl web sites to identify and extract targeted data, or the model can be installed on a user's computer to identify and extract targeted information from web sites as the user is browsing.

Abstract: A customer search terminal system may be configured to accept customer product searches and identify corresponding products and product information. A method for determining the efficacy of the customer search terminal may include receiving customer usage information including data related to customer usage of a customer search terminal and may also include receiving product sales information including data related to products sold at a point-of-sale terminal. The method may further include generating customer purchase behavior information by correlating the received customer search terminal usage information with the received product sales information when a product is sold at the point-of-sale terminal within a prescribed time period relative to a search for the product on the customer search terminal.

Abstract: A method and system is provided that in a fully automated manner crawls web sites and identifies specific types of web pages, then extracts targeted data from those web pages. One or more text nodes containing product-related information on a first web page are first identified, and the locations of those text nodes are described using one or more vectors. The vectors are then analyzed to identify one or more patterns and to generate a model from those patterns that discriminates between text nodes that contain product-related information and text nodes that do not contain product-related information on a second web page. The model can then be used to crawl web sites to identify and extract targeted data, or the model can be installed on a user's computer to identify and extract targeted information from web sites as the user is browsing.

Abstract: A customer search terminal system may be configured to accept customer product searches and identify corresponding products and product information. A method for determining the efficacy of the customer search terminal may include receiving customer usage information including data related to customer usage of a customer search terminal and may also include receiving product sales information including data related to products sold at a point-of-sale terminal. The method may further include generating customer purchase behavior information by correlating the received customer search terminal usage information with the received product sales information when a product is sold at the point-of-sale terminal within a prescribed time period relative to a search for the product on the customer search terminal.

Abstract: The invention relates to novel polypeptide analogues of GLP-1 and exendin-4. The polypeptide, in a preferred embodiment, is insulinotropic and long-acting. Preferably, the polypeptide's insulinotropic effect is comparable to or exceeds the effect of an equimolar amount of GLP-1 or exendin-4. The invention also relates to a method of treating a subject with diabetes, comprising administering to the subject the polypeptide of the invention in an amount that has an insulinotropic effect. The invention also relates to methods of using GLP-1, exendin-4, and polypeptide analogues thereof for neuroprotective and neurotrophic effects.

Abstract: The invention relates to novel polypeptide analogues of GLP-1 and exendin-4. The polypeptide, in a preferred embodiment, is insulinotropic and long-acting. Preferably, the polypeptide's insulinotropic effect is comparable to or exceeds the effect of an equimolar amount of GLP-1 or exendin-4. The invention also relates to a method of treating a subject with diabetes, comprising administering to the subject the polypeptide of the invention in an amount that has an insulinotropic effect. The invention also relates to methods of using GLP-1, exendin-4, and polypeptide analogues thereof for neuroprotective and neurotrophic effects.

Abstract: An herbal composition is used to relieve pain and other symptoms associated with migraines and other types of headaches. The preferred herbal composition includes white willow bark extract, kava kava root extract, feverfew extract, ginger root extract, Guarana extract, and Vitamin B6. The herbal composition may be combined with liposomes to carry the composition. The result is an herbal composition that can be applied sublingually for rapid, effective pain relief.